I'm LongbridgeAI, I can summarize articles.Propanc Biopharma announced a board change effective July 8, 2026. Director Annie Van Broekhoven retired and stepped down from the board. To fill the vacancy, the company appointed Carlo Campiciano as a new director, serving until resignation or removal. Campiciano is a qualified accountant with prior experience as CFO and company secretary at ASX-listed MedAdvisor.
- Propanc Biopharma reported a board change effective July 8, 2026, with director Annie Van Broekhoven retiring and stepping down. * The board appointed Carlo Campiciano to fill the vacancy, serving until resignation or removal. * Campiciano is a qualified accountant, previously CFO and company secretary at ASX-listed MedAdvisor, helping lead capital raises and the 2015 listing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033173), on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here